Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drivers with type-1 diabetes report increased incidence of car-crashes

28.07.2003


Drivers with type-1 diabetes reported higher numbers of driving mishaps according to a multi-center study led by researchers at the University of Virginia Health System. The study investigated whether or not diabetes treatments to control blood sugar level are associated with increased risks for driving mishaps. The results will be published in the August edition of Diabetes Care.

Hypoglycemia, or low blood sugar, occurs when blood glucose levels drop too low to properly fuel the body. A person with diabetes can become hypoglycemic by taking too much insulin or diabetes medication or by skipping meals. If blood sugar levels continue to fall, the lack of adequate glucose begins to impair brain and nervous system functions. Additional symptoms appear that affect behavior and judgment including confusion, blurred vision, mood changes, weakness and poor coordination.

“Becoming hypoglycemic while driving can prove hazardous,” said Daniel Cox, professor of psychiatric medicine at U.Va. Health System and principal investigator of the study. “Previous studies have looked at this problem but they did not distinguish between type 1 or type 2 diabetes and other factors that are important to a diabetic’s risk for driving mishaps.”



This study examined patients at diabetes specialty clinics at five U.S. and four European cities. Adults with type-1 diabetes, type-2 diabetes and non-diabetic adults were asked to complete an anonymous questionnaire.

The drivers with type-1 diabetes reported significantly more crashes, moving violations and hypoglycemic episodes than did patients with type-2 diabetes regardless of whether they used insulin. The type-2 diabetes group had driving mishap rates similar to non-diabetic drivers. However, only 20 percent of the drivers with type-1 diabetes were at increased risk of driving mishaps.

“We need to understand which diabetic drivers are at high-risk and why, in order to eventually develop a treatment program to lower this risk,” Cox said. “This research does not set out to restrict diabetic drivers, but instead provides information that physicians can use to talk with their patients about hypoglycemia and driving.”

The research also points out that drivers with type-1 diabetes are only one of several driver groups who are at increased risk of driving mishaps. Other groups include those younger than 21 and older than 60, those with attention deficit/hyperactivity disorder, those with sleep apnea and abusers of alcohol.

Cox recently received a $2.8 million grant from the National Institutes of Health to study the additional effects of hypoglycemia and driving. He is currently working with mathematician, Boris Kovatchev, to find an algorithm that can predict the onset of hypoglycemia.

“Ultimately, we want to reduce the incidence of hypoglycemia of at-risk drivers in order to reduce occurrences of driving mishaps,” Cox said.

Other institutions that participated in the study include the Joslin Diabetes Center in Boston, Mass., the University of Chicago in Ill., University of Louisville in Ky., Washington University in St. Louis, Mo., SUNY Institute of the Diabetes Academy in Mergentheim, Germany, and the Royal Infirmary in Edinburgh, Scotland

Daniel Cox | University of Virginia
Further information:
http://www.healthsystem.virginia.edu

More articles from Health and Medicine:

nachricht Uncuffing nitric oxide production: Beta-arrestin2 complexes regulate NO levels
05.06.2020 | Medical University of South Carolina

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Restoring vision by gene therapy

Latest scientific findings give hope for people with incurable retinal degeneration

Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major...

Im Focus: Small Protein, Big Impact

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.

Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

New image of a cancer-related enzyme in action helps explain gene regulation

05.06.2020 | Life Sciences

Silicon 'neurons' may add a new dimension to computer processors

05.06.2020 | Physics and Astronomy

Protecting the Neuronal Architecture

05.06.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>